PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Botulinum toxin type A - Overactive bladder (adults)
PAD Profile : Botulinum toxin type A - Overactive bladder (adults)
Keywords :
OAB, urinary incontinence
Brand Names Include :
Botox, Dysport
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Darifenacin hydrobromide
- Flavoxate hydrochloride
- Oxybutynin
- Propiverine hydrochloride
- Solifenacin
- Mirabegron
- Fesoterodine fumarate
- Trospium chloride
- Tolterodine
- Imipramine hydrochloride
Other Indications
- Migraine (prevention)
- Hypersalivation in children
- Movement disorders
- Gastroparesis
- Pyloric spasm (post GI surgery)
- Facial spasm
- Protective ptosis and squint
- Chronic sialorrhoea
- Spasmodic dysphonia
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
22 January 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN recommends Botulinum Toxin Type A for the treatment of overactive bladder that has been urodynamically proven, conservative measures have been exhausted and where the botulinum toxin is administered by an appropriately trained specialist
Botulinum Toxin Type A (Botox) is a payment by results excluded drug, which must be prescribed by hospital specialists only. Providers are required to invoice the commissioners for activity. Botulinum Toxin will be considered RED on the traffic light system.
Associated BNF Codes
07. Obstetrics, Gynaecology and Urinary-Tract Disorders
07.04.02. Drugs for urinary frequency enuresis and incontinence